Medical device company LeMaitre Vascular (NASDAQ: LMAT) will be reporting results tomorrow after the bell. Here’s what you need to know.
LeMaitre missed analysts’ revenue expectations by 0.7% last quarter, reporting revenues of $55.72 million, up 14% year on year. It was a mixed quarter for the company, with a solid beat of analysts’ full-year EPS guidance estimates but a slight miss of analysts’ EPS estimates.
Is LeMaitre a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting LeMaitre’s revenue to grow 8% year on year to $57.75 million, slowing from the 13.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.50 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. LeMaitre has missed Wall Street’s revenue estimates three times over the last two years.
Looking at LeMaitre’s peers in the healthcare equipment and supplies segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Intuitive Surgical delivered year-on-year revenue growth of 19.2%, beating analysts’ expectations by 3.1%, and Penumbra reported revenues up 16.3%, topping estimates by 2.7%. Intuitive Surgical traded up 1.9% following the results while Penumbra was also up 7.2%.
Read our full analysis of Intuitive Surgical’s results here and Penumbra’s results here.
Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the healthcare equipment and supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.6% on average over the last month. LeMaitre is up 8.7% during the same time and is heading into earnings with an average analyst price target of $105.63 (compared to the current share price of $92.60).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.